A detailed history of Simplex Trading, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 23,074 shares of SWTX stock, worth $929,420. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,074
Previous 21,093 9.39%
Holding current value
$929,420
Previous $794,000 6.93%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$32.04 - $42.76 $63,471 - $84,707
1,981 Added 9.39%
23,074 $739,000
Q2 2024

Jul 25, 2024

SELL
$36.06 - $47.62 $90,077 - $118,954
-2,498 Reduced 10.59%
21,093 $794,000
Q1 2024

Apr 25, 2024

BUY
$36.5 - $52.5 $742,045 - $1.07 Million
20,330 Added 623.43%
23,591 $1.16 Million
Q4 2023

Feb 02, 2024

BUY
$18.94 - $37.24 $52,918 - $104,048
2,794 Added 598.29%
3,261 $119,000
Q3 2023

Nov 01, 2023

BUY
$23.12 - $31.38 $10,797 - $14,654
467 New
467 $10,000
Q2 2022

Aug 03, 2022

BUY
$18.36 - $60.07 $101,549 - $332,247
5,531 New
5,531 $136,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.51B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.